[go: up one dir, main page]

NO20070705L - Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger - Google Patents

Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger

Info

Publication number
NO20070705L
NO20070705L NO20070705A NO20070705A NO20070705L NO 20070705 L NO20070705 L NO 20070705L NO 20070705 A NO20070705 A NO 20070705A NO 20070705 A NO20070705 A NO 20070705A NO 20070705 L NO20070705 L NO 20070705L
Authority
NO
Norway
Prior art keywords
phospholipid ether
methods
colonoscopy
viral
ray
Prior art date
Application number
NO20070705A
Other languages
English (en)
Norwegian (no)
Inventor
Jamey P Weichert
Mark A Longino
Original Assignee
Cellectar Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectar Llc filed Critical Cellectar Llc
Publication of NO20070705L publication Critical patent/NO20070705L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0408—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Dentistry (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO20070705A 2004-07-08 2007-02-07 Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger NO20070705L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52183104P 2004-07-08 2004-07-08
PCT/US2005/024259 WO2006014589A2 (fr) 2004-07-08 2005-07-08 Colonoscopie virtuelle comprenant l'utilisation d'analogues d'ethers phospholipidiques radiomarques

Publications (1)

Publication Number Publication Date
NO20070705L true NO20070705L (no) 2007-04-02

Family

ID=35503411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070705A NO20070705L (no) 2004-07-08 2007-02-07 Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger

Country Status (14)

Country Link
US (1) US7700075B2 (fr)
EP (1) EP1773408A2 (fr)
JP (1) JP2008508909A (fr)
KR (1) KR20070054630A (fr)
CN (1) CN101001647A (fr)
AU (1) AU2005269861A1 (fr)
BR (1) BRPI0511445A (fr)
CA (1) CA2572398A1 (fr)
IL (1) IL180363A0 (fr)
MX (1) MX2007000207A (fr)
NO (1) NO20070705L (fr)
NZ (1) NZ552914A (fr)
WO (1) WO2006014589A2 (fr)
ZA (1) ZA200700015B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437657T1 (de) * 2004-03-02 2009-08-15 Cellectar Inc Phospholipid-analoga für die behandlung von krebs
US8540968B2 (en) * 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
JP2008545614A (ja) * 2004-12-20 2008-12-18 セレクター、リミテッド ライアビリティ カンパニー 癌の検出および治療のためのリン脂質エーテル類似体
WO2006114658A2 (fr) * 2005-04-28 2006-11-02 Yeda Research And Development Co., Ltd Diagnostic du cancer du poumon sur la base de donnees d'imagerie par resonance magnetique obtenues a trois moments differents
US7414254B2 (en) * 2005-06-28 2008-08-19 United Pharmacy Partners, Inc. Tungsten pig for radio-pharmaceuticals
US20070208331A1 (en) * 2006-03-02 2007-09-06 Chu Michael S Systems and methods of treatment within a gastrointestinal lumen
EP1985713A1 (fr) * 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Procédés et outils pour la détection de la présence de cellules d'adénocarcinome colorectal
US20080319315A1 (en) * 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
WO2010011844A1 (fr) * 2008-07-25 2010-01-28 Tufts Medical Center Système et procédé de planification du traitement clinique de distributions de doses de curiethérapie complexe de type monte-carlo
US8871181B2 (en) 2009-05-11 2014-10-28 Cellectar, Inc. Fluorescent phospholipid ether compounds, compositions, and methods of use
EP2429591B1 (fr) 2009-05-11 2015-08-26 Cellectar, Inc. Composés d'éther de phospholipide fluorescents, compositions et procédés d'utilisation associés
SI2440253T1 (sl) * 2009-06-12 2020-09-30 Cellectar, Inc. Alkil fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic
WO2011031919A2 (fr) * 2009-09-11 2011-03-17 Cellectar, Inc. Composés phospholipidiques non radioactifs, compositions et procédés d'utilisation
NZ604040A (en) 2010-06-03 2015-02-27 Pharmacyclics Inc The use of inhibitors of bruton’s tyrosine kinase (btk)
KR101341288B1 (ko) 2013-10-24 2013-12-12 사회복지법인 삼성생명공익재단 방사선 치료기의 품질 보증 시스템 및 그 품질 보증 방법
JP2017509336A (ja) 2014-03-20 2017-04-06 ファーマサイクリックス エルエルシー ホスホリパーゼｃガンマ２及び耐性に関連した変異
EA037519B1 (ru) 2014-11-17 2021-04-07 Селлектар Байосайенсиз, Инк. Аналоги простых эфиров фосфолипидов в качестве носителей лекарственных средств, нацеленных на раковые клетки
US10839509B2 (en) 2015-07-10 2020-11-17 3Scan Inc. Spatial multiplexing of histological stains
US11147823B2 (en) * 2016-07-13 2021-10-19 Wisconsin Alumni Research Foundation Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors
KR102396334B1 (ko) * 2016-07-18 2022-05-09 위스콘신 얼럼나이 리서어치 화운데이션 인 시츄 면역 조절 암 백신화를 위한 방사성할로겐화 제제
RU2755010C1 (ru) * 2021-01-26 2021-09-09 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") Способ диагностики рака ободочной кишки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925649A (en) * 1987-06-12 1990-05-15 The University Of Michigan Radioiodinated diacylglycerol analogues and methods of use
US5347030A (en) * 1987-10-23 1994-09-13 The Board Of Regents Of The University Of Michigan Radioiodinated phospholipid ether analogues and methods of using same
US5087721A (en) * 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US6255519B1 (en) * 1996-12-04 2001-07-03 Regents Of The University Of Michigan Radioiodinated phospholipid ether analogs and methods of using the same
ATE437657T1 (de) * 2004-03-02 2009-08-15 Cellectar Inc Phospholipid-analoga für die behandlung von krebs
JP2008545614A (ja) * 2004-12-20 2008-12-18 セレクター、リミテッド ライアビリティ カンパニー 癌の検出および治療のためのリン脂質エーテル類似体
CN100415584C (zh) * 2005-02-04 2008-09-03 比亚迪股份有限公司 机动车制动防抱死的控制系统和方法

Also Published As

Publication number Publication date
MX2007000207A (es) 2007-03-30
NZ552914A (en) 2009-12-24
AU2005269861A1 (en) 2006-02-09
CA2572398A1 (fr) 2006-02-09
US20060013767A1 (en) 2006-01-19
AU2005269861A2 (en) 2006-02-09
BRPI0511445A (pt) 2007-12-26
WO2006014589A3 (fr) 2006-04-20
WO2006014589A2 (fr) 2006-02-09
EP1773408A2 (fr) 2007-04-18
US20070098633A2 (en) 2007-05-03
CN101001647A (zh) 2007-07-18
JP2008508909A (ja) 2008-03-27
KR20070054630A (ko) 2007-05-29
IL180363A0 (en) 2007-06-03
US7700075B2 (en) 2010-04-20
ZA200700015B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
NO20070705L (no) Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger
Ruigrok et al. Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
JP7608425B2 (ja) 線維芽細胞活性化タンパク質リガンドを含む化合物およびその使用
Sahlmann et al. Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
Lee et al. Target volume delineation for conformal and intensity-modulated radiation therapy
Davis et al. Stereotactic body radiotherapy for recurrent oropharyngeal cancer–influence of HPV status and smoking history
Warner et al. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer.
Longton et al. Individualized prophylactic neck irradiation in patients with cN0 head and neck cancer based on sentinel lymph node (s) identification: definitive results of a prospective phase 1-2 study
Kunert et al. Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer
Orosco et al. Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model
Rasaneh et al. Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines
Zettlitz et al. [89Zr] A2cDb immuno-PET of prostate cancer in a human prostate stem cell antigen knock-in (hPSCA KI) syngeneic model
Marafi et al. 68Ga–Prostate-Specific Membrane Antigen PET/CT in Cholangiocarcinoma: A Potential Biomarker for Targeted Radioligand Therapy?
Lengana et al. 68Ga-PSMA: a one-stop shop in radioactive iodine refractory thyroid cancer?
Rietbergen et al. Hybrid techniques for intraoperative sentinel lymph node imaging: early experiences and future prospects
Schrock et al. Laryngeal pleomorphic rhabdomyosarcoma
Lee et al. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience
Cashman et al. Role of positron emission tomography-computed tomography in head and neck cancer
Chow et al. Head and Neck Cancer of Unknown Primary: A Surgical Perspective
Moradi Positron Emission Tomography and Molecular Imaging of Head and Neck Malignancies
Mosci et al. FDG-PET/CT initial and subsequent therapy evaluation: progressing to PET/MR imaging
Baek et al. Mucosal melanoma arising in the eustachian tube
Walton et al. Multimodality imaging in parathyroid carcinoma: A tale of two nodules
Zhang et al. Imaging of human pancreatic cancer xenografts by single-photon emission computed tomography with 99mTc-Hynic-PEG-AE105
Amar et al. Neck dissection in squamous cell carcinoma of the tongue

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application